Approval · Notice of Compliance 11263 · 2010
FINASTERIDE: Notice of Compliance 11263
Issued April 20, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11263
- Date
- April 20, 2010
- Company
- Meliapharm IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Type II 5 alpha-reductase inhibitor
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FINASTERIDE | 02348888 | Cancelled Post Market |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB